Expression and Anti-breast Cancer Effect of Immunotoxin scFv-Mmut
DOI:
https://doi.org/10.54097/ijbls.v4i1.19Keywords:
Breast Cancer, Immunotoxin, Single Chain Antibody, Melittin Analogues, Express, ApoptosisAbstract
In this experiment, the Pichia Pastoris expression plasmid pPIC9K/scFv-Mmut was constructed, and the immunotoxin scFv-Mmut was successfully expressed in the eukaryotic expression system of Pichia Pastoris. The effect and mechanism of immunotoxin scFv-Mmut on inhibiting activity and inducing apoptosis of breast cancer cells were analyzed by in vitro assay. Through this experiment, it can be found that after the treatment of BT474 cells with a certain concentration of scFv-Mmut, the cell cycle will be affected and be blocked in the S phase, which proves that scFv-Mmut can induce the apoptosis of BT474 cells and has a significant anti-breast cancer effect.
Downloads
References
Ye Huilan. (2023) Effects of trastuzumab combined with chemotherapy on immune function and tumor marker levels of human epidermal growth factor receptor-2 positive metastatic breast cancer. Modern Medicine and Health Research (Electronic edition), 7(5):7-9.
Xu Weidong, Yao Huitao, Zhang Xinping, et al. (2021) Study on serum metabolomics of trastuzumab adjuvant therapy for human epidermal growth factor receptor-2 positive breast cancer based on ultra-high performance liquid chromatography-four-stage bar/electrostatic field orbital trap high resolution mass spectrometry. Chinese Primary Medicine, 28(2):184-189.
Qi Lin, Xiong Mengshang, Lin Fangzhen, et al. (2019) Construction of transmembrane anti-CD3 single chain antibody controlled by human AFP promoter and its specific expression in AFP positive hepatocellular carcinoma cells. Shandong Medicine, 59(29):1-4.
Jiang Yaling, Hu Xueli, Chen Hui, et al. (2019) Effect of chemokine CXCL12 and its ligands CXCR4 and CXCR7 on biological function of HER2-positive breast cancer cells. Chinese Journal of Immunology, 38(14):1722-1727.
Lei Bihui, Zhang Mengyao, Chen Xiaorui, et al. (2020) Effect of epigallocatechin gallate combined with trastuzumab on proliferation of HER2-overexpressed breast cancer cells and its mechanism. Journal of Pharmaceutical Practice, 40(2):136-142.
Wei Xiao, Chen Fangjun, Xin Kai, et al. (2019) Recent Advances in Immunotoxins: The combination of tumor targeted Therapy and immunotherapy?. Journal of Clinical Oncology, 24(7):643-648.
Peng Yanjie, Zhang Lin, Pang Zheng, et al. (2022) Study on freeze-drying process of recombinant immunotoxin TP25 for HER2-positive breast cancer. Chinese Journal of Pharmaceutical Industry, 53(10):1453-1457.
Li Cheng. (2022) Study on HER2-specific immunotoxin based on nano-antibody combined with PE38 toxin. Beijing University of Chemical Technology, Beijing.
Guo Yan, Zhang Changqing. (2018) Construction of bispecial single-chain antibody targeting HER2/EGFR molecule and its effect on breast cancer in vitro and in vivo. Laboratory Medicine and Clinic, 15(19):2887-2891.
Tan Z C, Zhang Y F, Huang X Y, et al. (2021) Long non-coding RNA TSI inhibits TGF-β1-mediated metastasis of MCF-7 and BT474 breast cancer cells. Lingnan Modern Clinical Surgery, 21(2):171-176.


